New York Added Newborn Testing for MLD
New York families can now access newborn screening for metachromatic leukodystrophy as part of the state's routine tests.
Updated on Oct. 5, 2026 in Babies
Live Poll
Should states prioritize funding universal newborn genetic screening despite high implementation costs?
New York launched standardized newborn screening for metachromatic leukodystrophy in September 2025. This testing helps identify the rare genetic disorder shortly after birth using standard blood samples.
Why it matters
Early detection allows for timely medical intervention, as states typically expand screening panels once effective gene therapies become available for previously untreatable conditions.
New York now screens newborns for 50 distinct diseases, including metachromatic leukodystrophy. While New York is among only three states currently performing this test, six additional states are expected to adopt the screening later this year.
The players
U.S. Department of Health and Human Services
The federal agency that oversees national health policy and manages the committee responsible for newborn screening panel recommendations.
FDA
The federal regulatory body that evaluates the safety and efficacy of medical treatments, including the gene therapy approved in 2024.
The details
Newborn screening for metachromatic leukodystrophy utilizes blood samples collected via a simple heel prick shortly after a baby is born. This process is funded in New York through federal grants that sustain operations. The expansion follows the 2024 FDA approval of a gene therapy designed to address the condition, providing a medical pathway that previously did not exist for affected infants.
Timeline
1965: New York began newborn screening for PKU.
September 2025: New York launched metachromatic leukodystrophy screening.
December 2025: Federal panel added metachromatic leukodystrophy to its list.
September 24, 2026: Federal bill introduced for newborn screening funding.
September 2027: New York's current federal grant funding expires.
The Home Front
The inclusion of this test follows the national precedent set by the Recommended Uniform Screening Panel to standardize care for rare genetic disorders. This shift reflects a broader trend of states expanding screening panels in response to recent breakthroughs in gene therapy technology.
Parents of newborns in New York should verify with their pediatrician that the full 50-disease screening panel was completed following birth. If you have concerns about genetic conditions, ask your provider for the latest information on the state's testing timeline.
The takeaway
New York has modernized its newborn screening to catch rare conditions like metachromatic leukodystrophy early. Discuss your infant's medical history and the results of their state-mandated heel-prick screening with your pediatrician at your next wellness check.
Further reading
Learn more about local health requirements and resources for your child in New York Babies.
Source note: This article includes information reported by Newsday.
Live Poll
Should states prioritize funding universal newborn genetic screening despite high implementation costs?
